57279-69-3 Usage
Uses
Used in Pharmaceutical Industry:
2-Bromo-4-ethoxy-1-nitro-benzene is used as a chemical intermediate for the synthesis of pharmaceuticals. Its unique structure allows it to be a key component in the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Bromo-4-ethoxy-1-nitro-benzene serves as an intermediate in the production of agrochemicals. Its properties make it suitable for the creation of compounds that can be used in pest control and crop protection, thereby supporting agricultural productivity.
Used in Dye Industry:
2-Bromo-4-ethoxy-1-nitro-benzene is utilized in the dye industry as an intermediate for the synthesis of various dyes. Its chemical structure contributes to the development of dyes with specific color properties, which are essential for applications in textiles, plastics, and other industries.
Used in Organic Compounds Manufacturing:
2-Bromo-4-ethoxy-1-nitro-benzene is also used in the manufacturing of various organic compounds. Its versatility in chemical reactions enables the production of a range of organic molecules for different applications across various industries.
It is important to handle 2-Bromo-4-ethoxy-1-nitro-benzene with care due to its potential health and environmental hazards. Proper safety measures should be taken during its use and disposal to minimize any risks associated with this chemical compound.
Check Digit Verification of cas no
The CAS Registry Mumber 57279-69-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,2,7 and 9 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 57279-69:
(7*5)+(6*7)+(5*2)+(4*7)+(3*9)+(2*6)+(1*9)=163
163 % 10 = 3
So 57279-69-3 is a valid CAS Registry Number.
57279-69-3Relevant academic research and scientific papers
IMIDAZO [4, 5 -C] PYRIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
-
Paragraph 00513, (2013/08/28)
Wherein R1, L1, R3, R4, Cy, L2 and R5 are as defined herein. Novel imidazolopyridines according to Formula I, able to inhibit JAK are disclosed, these compounds may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, allergic or inflammatory conditions, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.
POSITIVE ALLOSTERIC MODULATORS OF THE NICOTINIC ACETYLCHOLINE RECEPTOR
-
Page 57, (2010/02/08)
The invention provides compounds of Formula (I). These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals used to treat diseases or conditions in wh
